BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//TeuWebsite//Esdeveniments//CAT
BEGIN:VTIMEZONE
TZID:Europe/Madrid
X-LIC-LOCATION:Europe/Madrid
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19701025T030000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:19700329T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:69d68fea23042@euroblood.eu
DTSTAMP:20260408T172706Z
SUMMARY:Place of new complement blockers in the management of Hemolytic Paroxysmal Nocturnal Hemoglobinuria
DESCRIPTION:<p><img alt="" src="/media/upload/imatges/Webinars/A%20Risitano.jpg" /></p>

<p><strong>Professor Antonio M Risitano</strong> is Director of Hematology and Hematopoietic Stem Cell Transplantation at the AORN San Giuseppe Moscati in Avellino, and Professor of Hematology at the Federico II University of Naples. After his education at the Federico II University of Naples, Prof. Risitano spent 3 years at the Hematology Branch of the National Institutes of Health in Bethesda, where he dedicated to experimental work on the pathophysiology of bone marrow failure syndromes, under the guidance of Dr. Neal Young. In 2004 he moved back to Naples where he served as Research Associate and then Assistant Professor in the Hematology unit, focusing paroxysmal nocturnal hemoglobinuria, aplastic anemia as well as of stem cell transplantation. From 2010 to 2020 he was Director of the bone marrow transplantation unit and Associate Professor of Hematology at the Federico II University, before being appointed as Head of Hematology in Avellino in July 2020. Prof. Risitano pioneered the development of novel treatments for aplastic anemia and paroxysmal nocturnal hemoglobinuria through seminal preclinical and clinical works.</p>
DTSTART;TZID=Europe/Madrid:20221011T130000
DTEND;TZID=Europe/Madrid:20221011T140000
END:VEVENT
END:VCALENDAR
